The GENIE, FoundationInsights, and GuardantINFORM datasets identified 180, 627, and 627 patients with EGFR ex20ins, respectively, which accounted for ~ 7–8% of all EGFRm lung adenocarcinomas (Fig. 1). Here, EGFR is linked to lung adenocarcinoma.